ALEXANDRIA, Va., April 9 -- United States Patent no. 12,268,718, issued on April 8.
"Control of cellular redox levels" was invented by Elizabeth McKenna (Houston).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are compositions and methods for regulating redox status and/or reducing oxidative stress in a subject, the methods and compositions comprising TLR agonists comprising bacterial lysates and/or lysate fractions. Also disclosed are compositions and methods comprising bacterial lysates and/or lysate fractions formulated or administered in combination with one or more other therapeutic or pharmaceutical agents."
The patent was filed on Nov. 10, 2016, under Application No. 15/348,005.
*For...